Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Hong Kong Expanding Operations with Plans to Hire 100

NEW YORK (GenomeWeb) – BGI today said that it anticipates hiring 100 people for its Hong Kong office this year in order to meet growing business demand.

Established in 2010, BGI-Hong Kong currently employs about 140 people, and is applying for various international quality certifications with plans to conduct personalized genome sequencing for preventing and curing illnesses, BGI said.

"We expect to enter 10 to 20 new overseas markets next year via our Hong Kong research center," Sunny Cheung, laboratory manager of BGI Tech Solutions in Hong Kong, said in a statement.

BGI is based in Shenzhen, China and has operations throughout Asia, including Japan, Singapore, India, and other countries. It also has offices in the Middle East, Australia, and New Zealand. BGI Europe is headquartered in Copenhagen, Denmark, while BGI Americas is based in Cambridge, Mass.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.